Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05998824 · ClinicalTrials.gov registry record · NA
COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease
A NA study of Sickle Cell Disease and Vaccine Hesitancy, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT05998824 is a NA study of Sickle Cell Disease and Vaccine Hesitancy that has completed, run by Duke University. The registered enrollment target is 33 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05998824, a NA study of Sickle Cell Disease and Vaccine Hesitancy, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test an COVID-19 vaccination information video in adults with sickle cell disease. The main questions it aims to answer are why are some adults with sickle cell disease hesitant to receive COVID-19 vaccination and whether a COVID-19 vaccination information video tailored for people with sickle cell disease will reduce vaccine hesitancy. Participants will complete a brief survey before and after watching a short video with information on vaccine safety, efficacy, and the greater impact of COVID-19 infection on people with sickle cell disease.
Conditions Studied
Interventions
- BEHAVIORAL SCD-specific COVID-19 vaccination information (SCVI) video
Study Locations (1)
North Carolina
- Duke Adult Sickle Cell Program - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2023-09-19 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05998824
The ClinicalTrials.gov registry entry for NCT05998824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (89% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which SCD-specific COVID-19 vaccination information (SCVI) video is the first listed.
NCT05998824 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05998824 about?
NCT05998824 is a clinical study titled "COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease". The goal of this clinical trial is to test an COVID-19 vaccination information video in adults with sickle cell disease. The main questions it aims to answer are why are some adults with sickle cell disease hesitant to receive COVID-19 vaccination and whether a COVID-19 vaccination information video...
What is the current status of trial NCT05998824?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2023-09-19. Estimated completion is 2024-09-30.
What conditions does trial NCT05998824 study?
This clinical trial studies the following conditions: Sickle Cell Disease, Vaccine Hesitancy, COVID-19 Vaccine.
What interventions are being tested in trial NCT05998824?
The interventions under investigation include: SCD-specific COVID-19 vaccination information (SCVI) video (BEHAVIORAL).
Who is sponsoring clinical trial NCT05998824?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05998824 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.